New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
January 28, 2019 - Dr. Reddy’s Laboratories and its subsidiary, Promius Pharma announced the FDA approval of Tosymra (sumatriptan) nasal spray, for the acute treatment of migraine with or without aura in adults.
Download PDF
Return to publications
